COVID-19 in Bulgaria: 2302 New Cases, 94 People Dead in Last 24h
49 352 are the active cases of coronavirus in the country. This is indicated by a reference on the site of the Unified Information Portal.
The British-Swedish pharmaceutical company AstraZeneca has requested an extraordinary permit for the use in the United States of its latest drug, which prevents COVID-19 disease. The drug, currently called AZD7442, is intended for people with weak immune systems, which would make vaccination ineffective. Vaccines rely on the immune system to produce antibodies in response to the injection to protect the person from the coronavirus. AZD7442 works on a different principle, after artificially created antibodies build the drug, and the recipient does not have to wait for his body to respond by creating protective antibodies, explains Reuters.
The results of a phase III study were shown to the US Food and Drug Administration, which showed a 77% effectiveness of the drug. The results quoted by the regulator were taken in the third month after taking the drug, but the pharmaceutical company hopes to advertise the product as immunity for a whole year, as the people involved in the study will be monitored for the next 15 months. The drug was made thanks to the discovery of monoclonal antibodies by scientists at Vanderbilt University Medical Center, and its release in America would be a great success for the pharmaceutical company, since its vaccine has not yet been approved for use overseas. The company said talks with the United States and other governments were ongoing.
Similar therapies made on the same type of monoclonal antibodies are being developed by competitors, including Regeneron and GlaxoSmithKline. For now, AstraZeneca seems to have the upper hand in this process. Experts believe that this will not affect the approval of the company's vaccine in the United States, for which its management said it would submit documents in the second half of 2021. In the United States, vaccination against coronavirus is carried out with Moderna, Pfizer and Johnson & Johnson.
/Capital
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
Caretaker Prime Minister Dimitar Glavchev ordered the cancellation of the Council of Ministers' decision to establish the private Mom and Me Multiprofile Hospital for Active Treatment in Sofia, the government press service said on Saturday.
Bulgaria is set to establish its emergency air assistance service by the end of May, marking a significant step forward in the country's healthcare infrastructure
New data from the World Health Organization (WHO) underscores concerns over the global surge in antibiotic usage during the Covid-19 pandemic, potentially exacerbating the silent threat of antimicrobial resistance.
The Ministry of Health in Bulgaria has announced a significant initiative to provide free whooping cough vaccines to all pregnant women between 27 to 36 weeks of gestation
A recent UN report on the health behaviors of school-age children has unveiled concerning trends regarding alcohol and cigarette consumption among Bulgarian students, sparking widespread concern
In a recent announcement that's bound to catch attention, Bulgaria's Chief State Health Inspector, Assoc. Angel Kunchev, declared that the country will not be declaring an emergency epidemic situation due to the spread of whooping cough
UN Happiness Report: Bulgaria's Astonishing Leap in Rankings
Bulgaria: 3 Regions With Lowest Life Expectancy - EU Report 2022